Yayınlar & Eserler

Yayın Ağı
Makaleler 14
Tümü (14)
SCI-E, SSCI, AHCI (5)
SCI-E, SSCI, AHCI, ESCI (13)
ESCI (8)
Scopus (14)
TRDizin (3)

1. Antituberculosis drug–induced hypersensitivity: clinical characteristics and risk factors

Katran Z. Y., BULUT İ., BABALIK A., Keren M., TEPETAM F. M.
Allergologia et Immunopathologia , cilt.53, sa.5, ss.69-77, 2025 (SCI-Expanded, Scopus) Creative Commons License

2. Treatment Management in Hepatitis and Tuberculosis Coexistence

Kabil N. K., BABALIK A.
Van Medical Journal , cilt.32, sa.1, ss.41-47, 2025 (Scopus, TRDizin) Creative Commons License

3. Multidrug-Resistant Tuberculosis in the Child Presenting with ITP-like Clinic İTP Kliniğinde Başvuran Çok İlaca Dirençli Tüberküloz Olgusu

Parlak B., Yılmaz D., BABALIK A., Aslan S., Yılmaz S., Ergenç Z., et al.
Cocuk Enfeksiyon Dergisi , cilt.18, sa.2, ss.114-118, 2024 (ESCI, Scopus, TRDizin)

4. Evaluation of mycobacterial microscopy and culture results from clinical samples: A five-year analysis Klinik örneklerden izole edilen mikobakterilerin mikroskopi ve kültür sonuçlarının değerlendirilmesi: Beş yıllık analiz

Balikçi A., ERBAKAN M., BABALIK A.
Tuberkuloz ve Toraks , cilt.72, sa.3, ss.185-190, 2024 (ESCI, Scopus, TRDizin)

5. Comparison of Computed Tomography Findings in Lung Tuberculosis in Diabetic and Nondiabetic Patients

Turkar A., BABALIK A., Feyzullahoglu G.
International Journal of Mycobacteriology , cilt.13, sa.1, ss.40-46, 2024 (ESCI, Scopus)

6. Affecting Factors Unfavorable Treatment Outcomes of Rifampicin-resistant/Multidrug-resistant Tuberculosis Patients Treated with Long-term Regimen

BABALIK A., Balikçi A., Turkar A., Teke N. H., Demir F. K., Yavuz S., et al.
International Journal of Mycobacteriology , cilt.13, sa.3, ss.265-274, 2024 (ESCI, Scopus)

7. Drug hypersensitivity in drug-resistant tuberculosis

Katran Z. Y., BULUT İ., BABALIK A., Keren M., TEPETAM F. M., Mersin S. S., et al.
World Allergy Organization Journal , cilt.16, sa.5, 2023 (SCI-Expanded, Scopus)

8. Nontuberculous mycobacteria isolation from sputum specimens: A retrospective analysis of 1061 cases

BABALIK A., Koc E., Sekerbey H., Donmez G., Balikci A., Kilicaslan Z.
International Journal of Mycobacteriology , cilt.12, sa.1, ss.55-65, 2023 (ESCI, Scopus)

9. Management of type 1 immediate hypersensitivity reactions to antituberculosis drug: succesful desensitization

Katran Z. Y., BULUT İ., BABALIK A., Keren M.
Allergy, Asthma and Clinical Immunology , cilt.18, sa.1, 2022 (SCI-Expanded, Scopus)

10. Tuberculosis treatment-related lichenoid drug eruptions

Katran Z. Y., BULUT İ., BABALIK A.
International Journal of Mycobacteriology , cilt.11, sa.4, ss.469-471, 2022 (ESCI, Scopus)

11. Outcomes of latent tuberculosis infection treatment in Istanbul

GÜNER A. E., KIZILTAŞ Ş., BABALIK A., Sahin E., Sibel A., Safak M., et al.
International Journal of Mycobacteriology , cilt.11, sa.4, ss.442-447, 2022 (ESCI, Scopus)

12. Treatment and management of hypersensitivity reactions developed against anti-tuberculosis drug

Katran Z. Y., BULUT İ., BABALIK A., Keren M.
International Journal of Mycobacteriology , cilt.11, sa.3, ss.309-317, 2022 (ESCI, Scopus)

13. Evaluating the effectiveness of anti-tuberculosis treatment by detecting Mycobacterium tuberculosis 85B messenger RNA expression in sputum

ATAHAN E., SARIBAŞ A. S., DEMİRCİ M., BABALIK A., Akkus S., Balıkcı A., et al.
Journal of Infection and Public Health , cilt.13, sa.10, ss.1490-1494, 2020 (SCI-Expanded, Scopus)

14. A registry-based cohort study of pulmonary tuberculosis treatment outcomes in Istanbul, Turkey

BABALIK A., Kilicaslan Z., Sevkan Caner S., GÜNGÖR G., Gonenc Ortakoylu M., Gencer S., et al.
Japanese Journal of Infectious Diseases , cilt.66, sa.2, ss.115-120, 2013 (SCI-Expanded, Scopus)
Kitaplar 1

1. Tuberculosis: An Overview

KIZILTAŞ Ş., BABALIK A.
Airway Diseases: Volume 1-3, Springer International Publishing Ag, ss.635-659, 2023
Metrikler

Yayın

15

Yayın (WoS)

13

Yayın (Scopus)

15

H-İndeks (WoS)

6

Atıf (Scopus)

61

H-İndeks (Scopus)

6

Proje

1

Tez Danışmanlığı

6

Açık Erişim

3